Evidence map›Paper›PMID 27353332›Full record

ArticleNucleic acids research2016

Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors.

Yulia Demchenko, Anna Roschke, Wei-Dong Chen, Yan Asmann, Peter Leif Bergsagel, Walter Michael Kuehl

Abstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. MB4-2/MB4-3 transcripts ofOncotarget · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yulia DemchenkoGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4265, USA.
Anna RoschkeGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4265, USA.
Wei-Dong ChenGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4265, USA.
Yan AsmannDivision of Biomedical Statistics and Informatics, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL 32224, USA.
Peter Leif BergsagelComprehensive Cancer Center, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ 85259, USA.
Walter Michael KuehlGenetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4265, USA kuehlw@helix.nih.gov.

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Rafael Fonseca · 2015 to 2026
$25.5M
Mutations that Distinguish Benign from Malignant Plasma Cell NeoplasamsR01CA195688 · NCI · MAYO CLINIC ARIZONA · PI BERGSAGEL, PETER LEIF · 2016 to 2020
$1.9M
NCI NIH HHS P50 CA186781NCI NIH HHS R01 CA195688
6 · The paper itself

Abstract

Using a combination of array comparative genomic hybridization, mate pair and cloned sequences, and FISH analyses, we have identified in multiple myeloma cell lines and tumors a novel and recurrent type of genomic rearrangement, i.e. interchromosomal rearrangements (translocations or insertions) and intrachromosomal inversions that contain long (1-4000 kb; median ∼100 kb) identical sequences adjacent to both reciprocal breakpoint junctions. These duplicated sequences were generated from sequences immediately adjacent to the breakpoint from at least one-but sometimes both-chromosomal donor site(s). Tandem duplications had a similar size distribution suggesting the possibility of a shared mechanism for generating duplicated sequences at breakpoints. Although about 25% of apparent secondary rearrangements contained these duplications, primary IGH translocations rarely, if ever, had large duplications at breakpoint junctions. Significantly, these duplications often contain super-enhancers and/or oncogenes (e.g. MYC) that are dysregulated by rearrangements during tumor progression. We also found that long identical sequences often were identified at both reciprocal breakpoint junctions in six of eight other tumor types. Finally, we have been unable to find reports of similar kinds of rearrangements in wild-type or mutant prokaryotes or lower eukaryotes such as yeast.

Indexed as

Chromosome BreakageGene DuplicationGene RearrangementGenome, HumanBase SequenceChromosome InversionGene DosageGenes, DuplicateGenetic LociHumansModels, GeneticMultiple MyelomaProto-Oncogene Proteins c-mycProto-Oncogene Proteins c-myc

Identifiers

PMID27353332
PMCPMC5041460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.